ATH 33.3% 0.4¢ alterity therapeutics limited

congratulations prana

  1. 5,921 Posts.
    lightbulb Created with Sketch. 151
    You specified executive function and you scored a direct hit.
    Ira Shoulson said from the Alzheimer's results he thought it could help with executive function decline in HD and he was correct.
    This bodes very well for the coming AD results and extension trial. It has helped in brain atrophy, so there is a biomarker to back up the cognition result, and of course it passed the primary endpoint of safety with flying colors.

    Bring on the phase3 and the IMAGINE results.

    Holding through AD results.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.